Award

Manufacture of vaccine clinical lot

  • UNIVERSITY OF YORK

F15: Voluntary ex ante transparency notice

Notice identifier: 2022/S 000-015336

Procurement identifier (OCID): ocds-h6vhtk-03428e

Published 1 June 2022, 12:36pm



Section one: Contracting authority/entity

one.1) Name and addresses

UNIVERSITY OF YORK

Heslington

YORK

YO105DD

Contact

Dom Roebuck

Email

procurement@york.ac.uk

Telephone

+44 1904328201

Country

United Kingdom

NUTS code

UKE21 - York

Internet address(es)

Main address

https://www.york.ac.uk/

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Education


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Manufacture of vaccine clinical lot

two.1.2) Main CPV code

  • 73000000 - Research and development services and related consultancy services

two.1.3) Type of contract

Services

two.1.4) Short description

Manufacture of a clinical lot of leishmaniasis vaccine

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £1,072,764

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UKE21 - York

two.2.4) Description of the procurement

Manufacture of a clinical lot of leishmaniasis vaccine covering; Compatability study: Production and Testing of Tox Lot, Clinical Material: GMP Production and Testing of Drug Substance (DS), Clinical Material: Production and Testing of Drug Product (DP), Clinical Material:

two.2.11) Information about options

Options: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Negotiated without a prior call for competition

  • The works, supplies or services can be provided only by a particular economic operator for the following reason:
    • absence of competition for technical reasons

Explanation:

The University of York (including its associated entities) intends to contract with the enclosed provider for the manufacture of a vaccine clinical lot for a 42 month period commencing 1st July 2022 without a call for competition. The University's reasons are:

• The clinical lot is required to be compatible in manufacture with that previously used in clinical trials by the University of York, requiring manufacture using the cell line "Procell 92". The contractor were co-designers of the vaccine used in the clinical trials.

• Only the contractor is authorised by the owners of Procell 92 (GSK) to use this cell line for manufacture of a Leishmaniasis vaccine

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes


Section five. Award of contract/concession

A contract/lot is awarded: Yes

five.2) Award of contract/concession

five.2.1) Date of conclusion of the contract

1 June 2022

five.2.2) Information about tenders

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor/concessionaire

ADVENT SRL

Via Pontina km 30,600 00071 Pomezia (RM)

Pomezia

Country

Italy

NUTS code
  • IT - Italy
The contractor/concessionaire is an SME

Yes

five.2.4) Information on value of contract/lot/concession (excluding VAT)

Total value of the contract/lot/concession: £1,072,764


Section six. Complementary information

six.4) Procedures for review

six.4.1) Review body

Royal Courts of Justice

Strand

London

WC2A 2LL

Country

United Kingdom